Chairs and Speakers – D
Siddhartha Sankar Datta
Main position/role: Regional Adviser, Vaccine-preventable Diseases and Immunization Programme, WHO Regional Office for Europe
|Siddhartha Datta, a medical graduate from India with a Master’s in Public Health from Manchester Metropolitan University UK, has been involved in the field of immunization since 2004 when he joined the National Polio Surveillance Project (NPSP), WHO India as a Surveillance Medical Officer followed by his tenure as State Routine Immunization Officer in Uttar Pradesh under WHO-NPSP India. He joined WHO Papua New Guinea in 2010 and thereafter served in WHO Lao PDR as Immunization Team Lead until 2016. Upon his relocation to Vaccine-preventable Diseases and Immunization programme in WHO Europe in 2016, he has served in the Accelerated Disease Control team followed by managing the newly formed Immunization and Surveillance Data team as an acting Team Lead. Since Jan 2019, he is managing the Vaccine-Preventable Diseases and Immunization programme as the Regional Adviser. Over the past 17 years working in subnational, national and regional levels, Siddhartha has served in three WHO Regions and brings the experience of understanding the varied needs of the Member States. He has more than 20 publications to his credit until date in peer-reviewed journals on various aspects of the vaccine-preventable diseases.
Daniela De Biase
Main position/role: Associate Professor of Biochemistry, Sapienza University of Rome, Italy
Daniela De Biase, general secretary of the 2022 Regional Meeting of the World Health Summit, is Associate Professor at Sapienza University of Rome. She holds a degree in Biological Sciences (Sapienza), a PhD in Biochemistry (Cardiff University, UK), and has spent several research periods abroad. She teaches fundamental and medical Biochemistry in two courses of Medicine and Surgery and in other Health Sciences courses. Prof. De Biase is in the teachers’ board of the PhD course in Life Sciences and Erasmus Coordinator of Academic Mobility (Faculty of Pharmacy and Medicine). She is promoter of several EU and extra-EU bilateral-agreements for students/academic staff exchange. She is vice-chair and Grant Holder Scientific Representative of a EU-funded COST Action (CA18113) and actively participates in other Erasmus projects, including the CIVIS Alliance and DOMINOS (for online OSCE). She actively serves as Editor and reviewer for several journals.
Carlo Della Rocca
Main position/role: Full professor of Pathological Anatomy, Sapienza University of Rome; President of the Permant Conference of the Medical Faculties and Schools of Medicine and Surgery, Italy
|Carlo Della Rocca was born in Rome, Italy. He riceived is MD degree in Medicine and Surgery at Sapienza in 1985 and the certification for medical practice of Pathological Anatomy in 1989. He has been a Vising Fellow several times at memorial Sloan-Kettering Cancer Center, New York, and is the author of nearly 300 scientific papers published extensively in international journals. Full professor of Pathological Anatomy since 2006, from 2011 to 2017 he was President of the Degree Course in Medicine and Surgery (Latina Campus) of Sapienza University of Rome. from 2007 to 2017 he led the peer accreditation program (“On site visits”) of the Permanent Conference of the Presidents of the Master’s degree in Medicine and Surgery and he personally participated to over 20 on-site accreditation visits of italian Medical Degree courses. Since 2017 he is Dean of the Faculty of Pharmacy and Medicine of the “Sapienza”University of Rome and since the same year he is President of the Permant Conference of the Medical Faculties and Schools of Medicine and Surgery. Since 2020 he is member of the national Observatory of the Health Residency Programs.
Alessandra della Torre
Main position/role: Associate Professor of Parasitology, Sapienza University of Rome, Italy
AdT graduated in Biological Sciences (1987) and achieved a PhD in Microbiology and Epidemiology (1993). Since 2001, she coordinates the group of Medical Entomology in the Department of Public Health & Infectious Disease in Sapienza University of Rome. Research activities focus on mosquito vectors and mosquito-borne diseases, with specific focus on Afrotropical Anophelinae vectors and Culicinae vectors of arboviruses of public health concern in Europe. Researches are funded by EU (FP7 and H2020), NIH (USA), Italian Ministries of Research, of Health and of Defence and by Sapienza University. Scientific production is documented by 142 papers and several invitations as keynote speakers.
Main position/role: Senior Professor, Charité University Hospital Berlin, Germany
|MD served as Director of the Institute of Pathology and as head of the Board of Directors at Charité University Hospital Berlin and as Dean of the Medical Faculty. In the diagnostic field of surgical pathology, he is working on molecular pathology, predictive biomarkers and telepathology in connection with precision medicine. His scientific interests include prognosis of malignant tumours and molecular mechanisms of cytostatic drug resistance. He is on the editorial board of several scientific journals and the board of the WHO Classification of Tumours. He was president of the German Society of Pathology.
Stefania Di Marco
Main position/role: Scientific Director and Qualified Person, Advent S.r.l. , Pomezia, Italy
|Stefania has been working for the past 12 years in clinical research and in good manufacturing practices of adenovirus-based vaccines for Infectious Diseases (HCV, malaria, RSV, HIV, Ebola, leishmaniasis, rabies, HBV, RVF and SARS-CoV-2). She has 57 publications and four patents and 12-year experience in the evaluation of EU-funded research programmes (FP7, H2020, HORIZON, Eureka-Eurostars). Stefania worked for 18 years in preclinical drug discovery, employing molecular biology, biochemistry and X-ray crystallography (Novartis, Basel and IRBM-Merck, Pomezia).
She graduated in Biological Sciences in 1989, from the University of Rome La Sapienza and obtained a PhD in Cellular and Molecular Biology in 1994, from the University of Rome Tor Vergata.
Main position/role: Rotary International Polio Advocacy Adviser
|She has worked with Rotary International for more than 20 years on polio advocacy work with donor governments to secure funding for Polio eradication. Her work has taken her all over the world, participating in immunisation campaigns, high-level meetings, and working closely with partners in the Global Polio Eradication Initiative (GPEI).
She is a Member of International PolioPlus Committee (IPPC) and has chaired the IPPC Grants Sub Committee which recommends grants to WHO and Unicef up to $150million annually; and currently is Chair of the IPPC Sub Committee on Afghanistan. She is Coordinator of Rotary Global Polio Eradication Advocacy Task Force and UK National Advocacy Adviser,and is Dean of the Rotary Representatives to the UN and International Agencies.
Main position/role: President of North American Spine Society/ Clinical Professor, Arizona College of Medicine, USA
|President of the North American Spine Society, Dr. Dohring trained at Yale Medical School, Spine Institute of New England, & Harborview Hospital. Founder & director of the multidisciplinary Spine Institute of Arizona, he has trained over 25 spine surgery fellows, and has done IDE research on artificial disc replacement and minimally invasive surgery. Dedicated to education, he has lectured world- wide, and has been on the ACGME, ABOS, AAOS, & NASS Spine Surgery Residency/ Fellowship Guidelines Committees. Editorial Board member of The Spine Journal, he is corresponding author of “Lumbar Disc Nomenclature: Version 2.0”, the only paper published simultaneously in SPINE & The Spine Journal. He has volunteered his surgical skills in Ghana, Kenya, Tanzania, Haiti, Cambodia and Nepal. Outside the world of spine care, he is an avid mountain climber, and summited Mount Everest in 2019.
Main position/role: Executive Director, Global Regulatory Affairs Team, Precision Medicine and Companion Diagnostics, Bristol-Myers Squibb
Claudia currently heads the Global Regulatory Affairs team, Precision Medicine and Companion Diagnostics at Bristol-Myers Squibb. In her current role, she leads team that provides regulatory strategy support to the companion diagnostics and digital health elements of the BMS portfolio. Before joining BMS, she was responsible for the development and implementation of global regulatory strategies of companion diagnostics, medical devices and digital health products in the Merck Healthcare KGaA pipeline. She further served as a senior reviewer and acting chief of the hematology branch of the Office of In Vitro Diagnostics and Radiologic Health at the FDA. Claudia is a member of the EFPIA Precision Medicine Working Group. Claudia holds a PhD in Genetics and Genomics from Duke University Medical Center and completed postdoctoral training in Developmental Biology at the University of North Carolina, Chapel Hill.